Graybug Vision, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRAY research report →
Range $27.83 – $27.83
Price Chart
About the company
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye.
- CEO
- Frederic Guerard
- IPO
- 2020
- Employees
- 8
- HQ
- Redwood City, CA, US
Get TickerSpark's AI analysis on GRAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $120.98M
- P/E
- -4.07
- PEG
- 0.03
- P/S
- 0.00
- P/B
- 14975.92
- EV/EBITDA
- -8.93
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 3398.40%
- ROIC
- -122.56%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-23,121,000
- Net Income
- $-29,562,000-115.8%
- EPS
- $-1.97-61.5%
- OCF Growth
- -0.2%
- FCF Growth
- -0.2%
- 52W High
- $20.30
- 52W Low
- $4.88
- 50D MA
- $8.55
- 200D MA
- $11.51
- Beta
- 1.20
- RSI (14)
- 34
- Avg Volume
- 5.28K
No earnings-call transcripts are available for GRAY yet.
- Free Float
- 46.9%
- Shares Outstanding
- 22.00M
- Float Shares
- 10.32M
of shares held by institutions
22 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Johnson & Johnson Innovation - Jjdc, Inc. | 49.55K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 11, 23 | WILSON ROBERT N | buy | 506 |
| Nov 7, 23 | Leheny A. Rachel | buy | 2,000 |
| Nov 6, 23 | Roberts Eric W | buy | 2,400 |
| Nov 3, 23 | Roberts Eric W | buy | 11,249 |
| Nov 3, 23 | Roberts Eric W | buy | 3,700 |
| Nov 6, 23 | Leheny A. Rachel | buy | 2,440 |
| Nov 3, 23 | Hebbar Sudarshan | buy | 36,000 |
| Nov 3, 23 | Roberts Eric W | buy | 5,860 |
| Nov 3, 23 | Roberts Eric W | buy | 3,200 |
| Nov 3, 23 | Leheny A. Rachel | buy | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GRAY coverage
Recent articles, reports, and earnings notes.
No research on GRAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRAY report →GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
globenewswire.com · Aug 7
GRAY SETS DATE FOR SECOND QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL
globenewswire.com · Jul 8
Graycliff Announces LIFE Financing for Advancing Shakespeare Project
newsfilecorp.com · Jun 16
Grayscale Investments Launches the Lowest Gross Fee Hyperliquid ETP in the U.S. with Grayscale® Hyperliquid Staking ETF (Ticker: HYPG)
globenewswire.com · Jun 3
Graycliff Receives Drill Results up to 3030 g/t Gold over 1.0 metre at Shakespeare Gold Project, Ontario
newsfilecorp.com · Jun 2
GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE
globenewswire.com · May 7
Grayscale Investments® Announces Rebalancing of Multi-Asset Funds for First Quarter 2026
globenewswire.com · May 6
Graycliff Exploration Announces New CFO and Independent Director
newsfilecorp.com · May 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.